Second Sight Medical Products EYES
$ 4.1
-0.97%
Quarterly report 2024-Q3
added 11-13-2024
Second Sight Medical Products ROE Ratio 2011-2024 | EYES
Annual ROE Ratio Second Sight Medical Products
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-123.56 | -31.35 | -518.17 | 2214.29 | -461.75 | -1137.94 | -361.79 | -297.62 | -98.79 | -101.68 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
2214.29 | -1137.94 | -91.84 |
Quarterly ROE Ratio Second Sight Medical Products
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-102.35 | -95.27 | -92.94 | -62.49 | -59.72 | -31.07 | 74.29 | 438.97 | 386.92 | 140.53 | -136.02 | -673.41 | -429.25 | 52.91 | 705.56 | 2214.29 | 1914.02 | 1571.23 | 993.91 | -461.75 | -640.82 | -812.9 | -955.03 | -1137.94 | -944.71 | -753.59 | -582.27 | -361.79 | -360.81 | -351.75 | -341.21 | -297.62 | -231.62 | -174.51 | -115.74 | -24521.94 | -24534.15 | -24537.19 | -24541.46 | -101.68 | -62.46 | -40.38 | -18.6 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
2214.29 | -24541.46 | -2327.25 |